224 related articles for article (PubMed ID: 24837198)
1. MicroRNA-34A inhibits the growth, invasion and metastasis of gastric cancer by targeting PDGFR and MET expression.
Peng Y; Guo JJ; Liu YM; Wu XL
Biosci Rep; 2014 Jun; 34(3):. PubMed ID: 24837198
[TBL] [Abstract][Full Text] [Related]
2. MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer.
Garofalo M; Jeon YJ; Nuovo GJ; Middleton J; Secchiero P; Joshi P; Alder H; Nazaryan N; Di Leva G; Romano G; Crawford M; Nana-Sinkam P; Croce CM
PLoS One; 2013; 8(6):e67581. PubMed ID: 23805317
[TBL] [Abstract][Full Text] [Related]
3. MiR-484 suppressed proliferation, migration, invasion and induced apoptosis of gastric cancer via targeting CCL-18.
Liu J; Li SM
Int J Exp Pathol; 2020 Dec; 101(6):203-214. PubMed ID: 32985776
[TBL] [Abstract][Full Text] [Related]
4. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of microRNA-31 targeting integrin α5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells.
Zhang XB; Song L; Wen HJ; Bai XX; Li ZJ; Ma LJ
Tumour Biol; 2016 Jun; 37(6):8317-25. PubMed ID: 26729197
[TBL] [Abstract][Full Text] [Related]
6. microRNA-665 is down-regulated in gastric cancer and inhibits proliferation, invasion, and EMT by targeting PPP2R2A.
Zhang M; Wang S; Yi A; Qiao Y
Cell Biochem Funct; 2020 Jun; 38(4):409-418. PubMed ID: 31923339
[TBL] [Abstract][Full Text] [Related]
7. miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.
Riquelme I; Tapia O; Leal P; Sandoval A; Varga MG; Letelier P; Buchegger K; Bizama C; Espinoza JA; Peek RM; Araya JC; Roa JC
Cell Oncol (Dordr); 2016 Feb; 39(1):23-33. PubMed ID: 26458815
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-34a inhibits cell invasion and epithelial-mesenchymal transition via targeting AXL/PI3K/AKT/Snail signaling in nasopharyngeal carcinoma.
Jiang C; Cheng Z; Jiang T; Xu Y; Wang B
Genes Genomics; 2020 Aug; 42(8):971-978. PubMed ID: 32648233
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-937 inhibits cell proliferation and metastasis in gastric cancer cells by downregulating FOXL2.
Yu L; Chen J; Liu Y; Zhang Z; Duan S
Cancer Biomark; 2017 Dec; 21(1):105-116. PubMed ID: 29060929
[TBL] [Abstract][Full Text] [Related]
10. LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling.
Liu H; Deng H; Zhao Y; Li C; Liang Y
J Exp Clin Cancer Res; 2018 Nov; 37(1):279. PubMed ID: 30463570
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
12. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
13. Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA.
Mackiewicz M; Huppi K; Pitt JJ; Dorsey TH; Ambs S; Caplen NJ
Breast Cancer Res Treat; 2011 Nov; 130(2):663-79. PubMed ID: 21814748
[TBL] [Abstract][Full Text] [Related]
14. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.
Dai C; Xie Y; Zhuang X; Yuan Z
Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway.
Zheng Z; Yan D; Chen X; Huang H; Chen K; Li G; Zhou L; Zheng D; Tu L; Dong XD
PLoS One; 2015; 10(7):e0128751. PubMed ID: 26186594
[TBL] [Abstract][Full Text] [Related]
16. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-28 promotes cell proliferation and invasion in gastric cancer via the PTEN/PI3K/AKT signalling pathway.
Li L; Zhu X; Shou T; Yang L; Cheng X; Wang J; Deng L; Zheng Y
Mol Med Rep; 2018 Mar; 17(3):4003-4010. PubMed ID: 29257342
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
[TBL] [Abstract][Full Text] [Related]
19. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer.
Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L
EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-338 inhibits growth, invasion and metastasis of gastric cancer by targeting NRP1 expression.
Peng Y; Liu YM; Li LC; Wang LL; Wu XL
PLoS One; 2014; 9(4):e94422. PubMed ID: 24736504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
